Skip to main content

Find Clinical Trials

Home
Conditions
Stage III Cervical Cancer FIGO 2018

Clinical trial condition

Stage III Cervical Cancer FIGO 2018

Explore clinical trials studying Stage III Cervical Cancer FIGO 2018. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage III Cervical Cancer FIGO 2018 trial results

Active, Not Recruiting

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

NCT04580771

Conditions: Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB3 Cervical Cancer FIGO 2018, Stage II Cervical Cancer FIGO 2018, +11 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

NCT04574635

Conditions: Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Female Urogenital Diseases, +37 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details